Vaxart Inc - Company Profile

Powered by

All the sales intelligence you need on Vaxart Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Vaxart Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Vaxart Inc.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Vaxart Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Vaxart Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Steven Lo

Chief Executive Officer; Director; President Executive Board Since: 2024 Age: 59

Mr. Steven Lo has been the Chief Executive Officer, President, and Director of the company since 2024. Prior to this, he served as the Chief Executive Officer and Director at Valitor Inc from 2022 to 2024. Previously, he served as the President, Chief Executive Officer, and Director of Zosano Pharma Corporation from 2019 to 2022. Earlier, he served as the Chief Commercial Officer at Puma Biotechnology from 2015 to 2019.

Read Hide full bio of Steven Lo

Jeroen Grasman

Chief Financial Officer Senior Management Since: 2025

Mr. Jeroen Grasman has been the Chief Financial Officer of the company since May 2025. Prior to this, he served as the Chief Financial Officer at AltruBio from August 2021 to May 2025. Previously, he served as the Vice President of Finance and Operations at PACT Pharma. Mr. Grasman also served as the Vice President of Finance at Intarcia Therapeutics.

Read Hide full bio of Jeroen Grasman

James F. Cummings, M.D.

Chief Medical Officer Senior Management Since: 2021 Age: 60

Dr. James F. Cummings has been the Chief Medical Officer of the company since 2021. Prior to this, he served as the Director of the Department of Defense’s Global Emerging Infectious Surveillance and Response System (GEIS); Director of Translational Medicine and Regulated Activities for the Walter Reed Army Institute of Research (WRAIR); and Consultant to the Surgeon General for all medical research and development. Dr. Cumming also served as the President of Government and Public Health Solutions at ICON GPHS; and Vice President of Clinical Development and Translational Medicine at Novavax.

Read Hide full bio of James F. Cummings, M.D.

Sean Tucker, Ph.D.

Chief Scientific Officer; Senior Vice President Senior Management Since: 2010 Age: 58

Dr. Sean Tucker has been the Chief Scientific Officer and Senior Vice President of the company since 2010. Prior to this, he served as the Vice President of Research and Director of Immunology. Mr. Tucker also held numerous scientific and engineering roles at various biotechnology companies.

Read Hide full bio of Sean Tucker, Ph.D.

Edward B. Berg

General Counsel; Senior Vice President Senior Management Since: 2022 Age: 62
Gain a 360-degree view of Vaxart Inc and make more informed decisions for your business Gain a 360-degree view of Vaxart Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer